机构：[1]Ophthalmology, Univ of Miami Miller Sch of Med, Miami, Florida, United States[2]Ophthalmology, Xuanwu Hospital , Beijing, China眼科首都医科大学宣武医院[3]Everglades Biopharma, LLC, Miami, Florida, United States
第一作者机构：[1]Ophthalmology, Univ of Miami Miller Sch of Med, Miami, Florida, United States
推荐引用方式(GB/T 7714)：
Wei Li,Michelle LeBlanc,Weiwen Wang,et al.Secretogranin III as a novel target for anti-angiogenic therapy of choroidal neovascularization[J].INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE.2018,59(9):
APA：
Wei Li,Michelle LeBlanc,Weiwen Wang,Yanli Ji,Dachuan Liu...&Hong Tian.(2018).Secretogranin III as a novel target for anti-angiogenic therapy of choroidal neovascularization.INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE,59,(9)
MLA：
Wei Li,et al."Secretogranin III as a novel target for anti-angiogenic therapy of choroidal neovascularization".INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE 59..9(2018)
医学